Theta power for frontal midline ROI. by Anita B. Frohlich (20660615)

“…We found that paced nostril breathing both decreased alpha/mu oscillations over central and parietal areas and increased frontal midline and occipital theta oscillations when comparing to spontaneous breathing. …”

Variables name and variable measurement. by Jinyuan Li (5927267)

“…Using the medical insurance records from 2017 to 2022, we evaluated the impact of the DRG system on medical costs, service efficiency and healthcare quality.…”

Correlation diagram of each parameter in each group. by Neng Pan (5262032)

Chitosan-Based Thermal-Coagulation Hydrogel System Driven by Multiple Interactions: Oxidation-Induced Fast Gelation and Enhanced Performance by Yifan Liu (219681)

“…By controlling the grafting rate, it was found that the solution pH and p<i>K</i>_a of CS-C were both affected by the decrease of the amino groups, whereas the gelation time and the required β-GP content for gelling significantly decreased. …”

Chitosan-Based Thermal-Coagulation Hydrogel System Driven by Multiple Interactions: Oxidation-Induced Fast Gelation and Enhanced Performance by Yifan Liu (219681)

“…By controlling the grafting rate, it was found that the solution pH and p<i>K</i>_a of CS-C were both affected by the decrease of the amino groups, whereas the gelation time and the required β-GP content for gelling significantly decreased. …”

Chitosan-Based Thermal-Coagulation Hydrogel System Driven by Multiple Interactions: Oxidation-Induced Fast Gelation and Enhanced Performance by Yifan Liu (219681)

“…By controlling the grafting rate, it was found that the solution pH and p<i>K</i>_a of CS-C were both affected by the decrease of the amino groups, whereas the gelation time and the required β-GP content for gelling significantly decreased. …”

The raw data for Fig 4. by Hongjoo An (21703199)

“…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”

The raw data for S2 Fig. by Hongjoo An (21703199)

“…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”

The raw data for Fig 6. by Hongjoo An (21703199)

“…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”

The raw data for S4 Fig. by Hongjoo An (21703199)

“…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”

Functional Characterization of a Highly Efficient UDP-Glucosyltransferase CitUGT72AZ4 Involved in the Biosynthesis of Flavonoid Glycosides in Citrus by Bin Liao (714989)

“…Virus-induced gene silencing of <i>CitUGT72AZ4</i> significantly decreased the accumulation of flavonoid 4′-<i>O</i>-glucosides. …”

The raw data for Fig 5B. by Hongjoo An (21703199)

“…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”

The raw data for Fig 8A. by Hongjoo An (21703199)

“…Luciferase assay and human and mouse brain multi-omics data show that, during the differentiation of OL precursor cells (OPCs) into OLs, the enhancer activity of Sox10-E1 does not change while that of Sox10-E2 decreases significantly. Chromatin interaction data indicate that the two <i>Sox10</i> enhancers lie close to the border of the <i>Sox10</i> topologically associating domain (TAD). …”

Establishment of a diabetic rat model. by Lan Zeng (638254)

“…The abnormal production and release of VEGF promote the proliferation and migration of endothelial cells (ECs), which are critical drivers of retinal neovascularization [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0312791#pone.0312791.ref019" target="_blank">19</a>]. Accordingly, we measured VEGF gene expression and found that it was significantly increased in the retinas of diabetic rats (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0312791#pone.0312791.g003" target="_blank">Fig 3A</a>). …”

Probability of Cost-Effectiveness Across CET. by Yiping An (20609789)

“…Scenario analyses conducted over a time horizon extending from 10 to 30 years showed that the ICER decreased significantly with longer follow-up, gradually approaching the 0.51GDP threshold and remaining below the 0.90 GDP threshold throughout the analysis.…”

Base-case analysis. by Yiping An (20609789)

“…Scenario analyses conducted over a time horizon extending from 10 to 30 years showed that the ICER decreased significantly with longer follow-up, gradually approaching the 0.51GDP threshold and remaining below the 0.90 GDP threshold throughout the analysis.…”

Patient selection flowchart. by Aihong Zheng (20571034)

Effect of 1.25% of SCFP on MDR <i>Salmonella</i> serovars reduction at 24h. by Elena G. Olson (10649705)

Flowchart of included and excluded patients. by P.G.J. ter Horst (21743830)

“…<div><p>Medication can affect semen quality by decreasing ejaculate volume, sperm concentration, or decreased sperm motility and sperm function in general. …”

Characteristics of the study group. by P.G.J. ter Horst (21743830)

“…<div><p>Medication can affect semen quality by decreasing ejaculate volume, sperm concentration, or decreased sperm motility and sperm function in general. …”